Summary

The nutraceutical gummies market is estimated at USD 24.39 billion in 2025 and is projected to reach USD 47.80 billion by 2030, at a CAGR of 14.4%. The global nutraceutical gummies market is experiencing significant growth, driven by rising rates of vitamin deficiency and undernutrition, a growing focus on preventive health and wellness, rising consumer interest in beauty and wellness, expanding e-commerce and DTC channels, and an increasing preference for the gummy delivery format over traditional pills and capsules. Additionally, growth in plant-based and sugar-free gummies, increasing reliance of startups and D2C brands on turnkey contract manufacturing, and geographic expansion with localized formulation expertise are expected to create significant opportunities in the nutraceutical gummies market.
However, high production costs and ingredient stability issues, regulatory complexities across regions, and the complexity of maintaining batch-to-batch consistency and stability are expected to pose challenges in the nutraceutical gummies market. Furthermore, increasing audit expectations from global brand owners and intense market competition and brand differentiation also remain technical challenges.

https://mnmimg.marketsandmarkets.com/Images/nutraceutical-gummies-market-img-overview.webp

“Immunity support function is expected to hold a dominant market share during the forecast period.”
The popularity of nutraceutical gummies is growing because of their convenient form, size, and ease of consumption. The benefits of multivitamin gummies for boosting immunity also play a key role in the increased demand for nutraceutical gummies. Gummies offer the fastest growth potential for vitamin and mineral supplements. The market for immunity-specific gummy supplements is expected to grow as more people become aware of how nutrition affects their health and of the specific issues that can be addressed through lifestyle factors.
“The online channel segment in the B2C segment is expected to hold a significant market share among the sales channels in the nutraceutical gummies market.”
With rising awareness, demand, and traction, nutraceutical gummies have become a mainstream market staple. The increase in demand for these products has led to a rise in sales across various countries and regions, facilitated by both online and offline distribution channels. Key players are increasingly adopting and navigating their investments in distribution channels to make their products available to a wider consumer base. In addition, nutraceutical gummies manufacturing companies are promoting their products in the market through strategies such as online retailing, a part of the non-store-based distribution channel, which is expected to drive demand.
“Europe is expected to hold a significant share in the global nutraceutical gummies market during the forecast period.”
Companies operating in this region are also investing in expansions and acquisitions to meet the growing demand from the dietary supplements industry, including nutraceutical gummies. The growing demand for nutraceutical gummies in Europe is attributed to fast-paced lifestyles, health-conscious consumers, and urbanization. In 2020, Unilever acquired SmartyPants Vitamins, a US-based vitamin, mineral & supplement company. SmartyPants utilizes a range of sustainably sourced, bioavailable nutrients and non-GMO-certified ingredients. Its product line is free of artificial preservatives, sweeteners, colors, and flavors. This has made Unilever expand its product portfolio and serve more consumers in Europe.

In-depth interviews have been conducted with chief executive officers (CEOs), directors, and other executives from various key organizations operating in the nutraceutical gummies market.
? By Company Type: Tier 1 ? 25%, Tier 2 ? 45%, and Tier 3 ? 30%
? By Designation: CXOs ? 25%, Managers ? 40%, Others ? 35%
? By Region: North America ? 25%, Europe ? 25%, Asia Pacific ? 35%, South America ? 10%, and Rest of the World ?5%
Prominent companies in the market include?Brand Manufacturers: Church & Dwight Co., Inc. (US), H&H Group (Hong Kong), Amway (US), Bayer AG (Germany), Haleon (UK), Nestl? (Switzerland), Unilever (US), Otsuka Holdings Co., Ltd. (Japan), PharmaCare Laboratories Australia (Australia), Swanson (US), IM Healthcare (India), SMP Nutra (US), Nature’s Truth (US) and Herbaland Naturals Inc. (Canada) and Contract Manufacturers: Sofgen Pharma (Luxembourg), Catalent, Inc. ( US), Activ'Inside ( France), WinNutra (US), Makers Nutrition, LLC (US), Ion Labs (US), Vitajoy Group (China), Bliss Lifesciences LLP (India), Global Widget, LLC (US), Gummy Worlds (Turkey), TopGum (Israel), MeriCal (US), Fexmentis Life Sciences (India), and Eagle Labs, Inc. (US) among others.
Research Coverage
This research report categorizes the nutraceutical gummies market by type (B2B market and B2C market); customer type (B2B) (brand owners and marketing companies, retailers and distributors, healthcare and wellness providers, pharmaceutical companies, and food & beverage companies); production capacity (B2B) (small-scale contract manufacturers (< 10 m units/year), mid-scale manufacturers (10?50 m units/year), and large-scale industrial manufacturers (50 m+ units/year)); ingredient source (B2B) (animal-based source, plant-based source, microbial/fermentation-derived sources, and synthetic/chemically-derived sources); gummy base/excipients (B2B) (gelatin-based gummies, pectin-based gummies, starch-based gummies, agar, carrageenan, and other hydrocolloids); product type (B2C) (vitamins, minerals, omega-3 fatty acids, probiotics and prebiotics, collagen and beauty-from-within, herbal and botanical supplements, dietary fiber, CBD and cannabis-derived, and specialty formulations); functionality (B2C) (immunity support, general health & wellness, bone & joint health, weight management, beauty & skin health, and other functionalities); demographics (B2C) (generation alpha (0?12 years), generation Z (13?28 years), millennials (gen Y) (29?44 years), generation X (45?60 years), and baby boomers & older (61+ years)); sales channel (offline and online); and region (North America, Europe, Asia Pacific, South America, and Rest of the World).
The report’s scope encompasses detailed information on the major factors, including drivers, restraints, challenges, and opportunities, which influence the growth of the nutraceutical gummies industry. A thorough analysis of key industry players has been conducted to provide insights into their businesses, services, key strategies, contracts, partnerships, agreements, product launches, mergers & acquisitions, and recent developments in the nutraceutical gummies market. This report provides a competitive analysis of emerging startups in the nutraceutical gummies market ecosystem. Furthermore, the study covers industry-specific trends, including technology analysis, ecosystem & market mapping, and patent & regulatory landscape, among others.
Reasons to Buy This Report
The report provides market leaders/new entrants with information on the closest approximations of revenue numbers for the overall nutraceutical gummies and their subsegments. It will help stakeholders understand the competitive landscape and gain more insights to better position their businesses and plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the market and provides them with information on key market drivers, restraints, challenges, and opportunities.
The report provides insights into the following pointers:
? Analysis of key drivers (increasing preference for gummy delivery format over traditional pills and capsules, driving production volume), restraints (ingredient sourcing volatility), opportunities (increasing reliance of startups and D2C brands on turnkey contract manufacturing), and challenges (increasing audit expectations from global brand owners), influencing the growth of the nutraceutical gummies market
? Product Development/Innovation: Detailed insights into research & development activities and new product launches in the nutraceutical gummies market
? Market Development: Comprehensive information about lucrative markets?analysis of nutraceutical gummies across varied regions
? Market Diversification: Exhaustive information about new product sources, untapped geographies, recent developments, and investments in the nutraceutical gummies market
? Competitive Assessment: In-depth assessment of market shares, growth strategies, product offerings, brand/product comparison, and product footprints of leading players such as Brand Manufacturers: Church & Dwight Co., Inc. (US), H&H Group (Hong Kong), Amway (US), Bayer AG (Germany), Haleon (UK), Nestl? (Switzerland), Unilever (US), Otsuka Holdings Co., Ltd. (Japan), PharmaCare Laboratories Australia (Australia), Swanson (US), IM Healthcare (India), SMP Nutra (US), Nature’s Truth (US) and Herbaland Naturals Inc. (Canada) and Contract Manufacturers: Sofgen Pharma (Luxembourg), Catalent, Inc. (US), Activ'Inside (France), WinNutra (US), Makers Nutrition, LLC (US), Ion Labs (US), Vitajoy Group (China), Bliss Lifesciences LLP (India), Global Widget, LLC (US), Gummy Worlds (Turkey), TopGum (Israel), MeriCal (US), Fexmentis Life Sciences (India), and Eagle Labs, Inc. (US), among other players in the nutraceutical gummies market.

ページTOPに戻る

Table of Contents

1 INTRODUCTION 49 1.1 STUDY OBJECTIVES 49 1.2 MARKET DEFINITION 49 1.2.1 INCLUSIONS AND EXCLUSIONS 50 1.3 STUDY SCOPE 52 1.4 YEARS CONSIDERED 53 1.5 CURRENCY CONSIDERED 53 1.6 UNIT CONSIDERED 54 1.7 STAKEHOLDERS 54 2 EXECUTIVE SUMMARY 55 2.1 MARKET HIGHLIGHTS AND KEY INSIGHTS 55 2.2 KEY MARKET PARTICIPANTS: MAPPING OF STRATEGIC DEVELOPMENTS 57 2.3 DISRUPTIVE TRENDS IN NUTRACEUTICAL GUMMIES MARKET 58 2.4 HIGH GROWTH SEGMENTS 59 2.5 REGIONAL SNAPSHOT: MARKET SIZE, GROWTH RATE, AND FORECAST 60 3 PREMIUM INSIGHTS 61 3.1 ATTRACTIVE OPPORTUNITIES FOR PLAYERS IN NUTRACEUTICAL GUMMIES MARKET 61 3.2 B2B NUTRACEUTICAL GUMMIES MARKET, BY PRODUCTION CAPACITY AND REGION 62 3.3 B2C NUTRACEUTICAL GUMMIES MARKET, BY PRODUCT TYPE AND REGION 63 3.4 B2B NUTRACEUTICAL GUMMIES MARKET, BY CUSTOMER TYPE 63 3.5 B2B NUTRACEUTICAL GUMMIES MARKET, BY INGREDIENT SOURCE 64 3.6 B2C NUTRACEUTICAL GUMMIES MARKET, BY DEMOGRAPHICS 64 3.7 B2B NUTRACEUTICAL GUMMIES MARKET, BY COUNTRY 65 3.8 B2C NUTRACEUTICAL GUMMIES MARKET, BY COUNTRY 65 4 MARKET OVERVIEW 66 4.1 INTRODUCTION 66 4.2 MARKET DYNAMICS 67 4.2.1 DRIVERS 67 4.2.1.1 Rising rate of vitamin-deficiency diseases and undernutrition 67 4.2.1.2 Growing consumer interest in beauty and wellness 68 4.2.1.3 Innovation in functional formulations 69 4.2.1.4 Growth in gummy supplement launches and custom gummy programs 70 4.2.1.5 Increasing preference for gummy delivery format over traditional pills and capsules 70 ? 4.2.2 RESTRAINTS 71 4.2.2.1 Regulatory complexities across regions 71 4.2.2.2 Sugar content and health concerns 71 4.2.2.3 Ingredient sourcing volatility 72 4.2.2.4 Complexity in maintaining batch-to-batch consistency and stability 72 4.2.3 OPPORTUNITIES 72 4.2.3.1 Rising popularity of plant-based and sugar-free gummies 72 4.2.3.2 Expansion into personalized and AI-driven nutrition 73 4.2.3.3 Increasing reliance of startups and D2C brands on turnkey contract manufacturing 73 4.2.3.4 Geographic expansion with localized formulation expertise 74 4.2.4 CHALLENGES 74 4.2.4.1 Limited bioavailability and nutrient degradation 74 4.2.4.2 Intense market competition and brand differentiation 75 4.2.4.3 Logistics issues: Melting, deformation, and transit stability 75 4.2.4.4 Increasing audit expectations from global brand owners 75 4.3 UNMET NEEDS AND WHITE SPACES 76 4.3.1 UNMET NEEDS IN NUTRACEUTICAL GUMMIES MARKET 76 4.3.2 WHITE SPACE OPPORTUNITIES 77 4.4 INTERCONNECTED MARKETS AND CROSS-SECTOR OPPORTUNITIES 78 4.4.1 INTERCONNECTED MARKETS 78 4.4.2 CROSS-SECTOR OPPORTUNITIES 79 4.5 STRATEGIC MOVES BY TIER-1/2/3 PLAYERS 80 4.5.1 KEY MOVES AND STRATEGIC FOCUS 80 5 INDUSTRY TRENDS 81 5.1 PORTER’S FIVE FORCES ANALYSIS 81 5.1.1 INTENSITY OF COMPETITIVE RIVALRY 82 5.1.2 BARGAINING POWER OF SUPPLIERS 82 5.1.3 BARGAINING POWER OF BUYERS 82 5.1.4 THREAT OF SUBSTITUTES 82 5.1.5 THREAT OF NEW ENTRANTS 82 5.2 MACROECONOMICS OUTLOOK 83 5.2.1 INTRODUCTION 83 5.2.1.1 Macroeconomic indicators - B2C market 83 5.2.1.1.1 US-China trade tariff fluctuations reshape nutraceutical gummies market 83 5.2.1.1.2 Inflation and raw material costs reshape nutraceutical gummies market 84 5.2.1.1.2.1 Sweeteners and sugar inputs 84 5.2.1.1.2.2 Gelling agents: Gelatin, pectin, and alternatives 84 5.2.1.1.2.3 Vitamins, actives, flavors, and specialty additives 84 5.2.1.1.2.4 Energy, transportation, and packaging inflation 85 5.2.1.2 Macroeconomic indicators - B2B market 85 5.2.1.2.1 Population aging and chronic disease burden influencing preventive health and nutraceutical market expansion 85 5.3 VALUE CHAIN ANALYSIS 86 5.3.1 RAW MATERIAL & FUNCTIONAL INGREDIENT SOURCING 87 5.3.2 PRODUCT DEVELOPMENT AND MANUFACTURING 88 5.3.3 QUALITY, SAFETY, AND REGULATORY COMPLIANCE 88 5.3.4 PACKAGING & LABEL CUSTOMIZATION 89 5.3.5 MARKETING AND DISTRIBUTION 89 5.3.6 END USERS 89 5.4 ECOSYSTEM ANALYSIS 89 5.4.1 DEMAND SIDE 89 5.4.2 SUPPLY SIDE 90 5.5 PRICING ANALYSIS 91 5.5.1 AVERAGE SELLING PRICE (ASP) OF NUTRACEUTICAL GUMMIES, BY KEY PLAYER 91 5.5.2 AVERAGE SELLING PRICE (ASP) TREND OF NUTRACEUTICAL GUMMIES, BY REGION 94 5.6 TRADE ANALYSIS 96 5.6.1 EXPORT SCENARIO OF HS CODE 210690, BY KEY COUNTRY, 2020?2024 (MT) 96 5.6.2 IMPORT SCENARIO OF HS CODE 210690, BY KEY COUNTRY, 2020?2024 (MT) 96 5.7 KEY CONFERENCES AND EVENTS, 2026?2027 98 5.8 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS 99 5.9 INVESTMENT AND FUNDING SCENARIO 99 5.10 CASE STUDY ANALYSIS 100 5.10.1 NESTL? HEALTH SCIENCE ? EXPANDED COLLAGEN & FUNCTIONAL PORTFOLIO THROUGH MAJORITY STAKE ACQUISITION OF VITAL PROTEINS 100 5.10.2 SIRIO PHARMA ? EXPANDING NUTRACEUTICAL GUMMY AND PLANT-BASED SOFTGEL MANUFACTURING THROUGH ACQUISITION OF BEST FORMULATIONS 100 5.10.3 TOPGUM INDUSTRIES ? EXPANDING PHARMA GRADE AND HIGH VOLUME GUMMY MANUFACTURING THROUGH ACQUISITION OF ISLAND ABBEY NUTRITIONALS 101 5.10.4 GILLCO/IFF GRINDSTED ? ENHANCING GUMMY GELATION AND PROCESS STABILITY USING SLOW-SET PECTIN 102 5.11 IMPACT OF 2025 US TARIFF ? NUTRACEUTICAL GUMMIES MARKET 102 5.11.1 INTRODUCTION 102 5.11.2 KEY TARIFF RATES 103 5.11.3 PRICE IMPACT ANALYSIS 104 5.11.4 IMPACT ON COUNTRIES/REGIONS 104 5.11.4.1 US 104 5.11.4.2 Europe 105 5.11.4.3 Asia Pacific 105 5.11.5 IMPACT ON END-USE INDUSTRIES 105 6 TECHNOLOGY ADVANCEMENTS, AI-DRIVEN IMPACT, PATENTS, INNOVATIONS, AND FUTURE APPLICATIONS 107 6.1 TECHNOLOGY ANALYSIS 107 6.1.1 KEY TECHNOLOGIES 107 6.1.1.1 Gelling and texture technology 107 6.1.1.1.1 Starch-based gelling technology 108 6.1.1.1.2 Starchless gelling technology 108 6.1.1.2 Microencapsulation technology (taste masking & flavor) 108 6.1.2 COMPLEMENTARY TECHNOLOGIES 109 6.1.2.1 Coating technology 109 6.1.2.2 Nutrient stabilization methods 109 6.1.2.3 Flavor release systems 110 6.1.3 ADJACENT TECHNOLOGIES 110 6.1.3.1 3D-printing & personalized dosing platforms 110 6.1.3.2 Plant-based and clean-label ingredient technologies 110 6.1.3.3 Smart packaging 111 6.2 TECHNOLOGY/PRODUCT ROADMAP 111 6.2.1 SHORT-TERM | FOUNDATION & EARLY COMMERCIALIZATION 111 6.2.2 MID-TERM | EXPANSION & STANDARDIZATION 112 6.2.3 LONG-TERM | PRECISION NUTRITION & SMART CALCIUM SOLUTIONS 112 6.3 PATENT ANALYSIS 112 6.4 FUTURE APPLICATIONS 114 6.4.1 GELATIN-FREE, REDUCED-SUGAR FUNCTIONAL GUMMIES ENRICHED WITH PGH EXTRACT 114 6.4.2 MICROENCAPSULATION OF VITAMIN C FOR IMPROVED STABILITY IN NUTRACEUTICAL GUMMIES 115 6.4.3 3D-PRINTED PATIENT-TAILORED MEDICINAL GUMMIES FOR PEDIATRIC DRUG DELIVERY 115 6.4.4 EDIBLE ACTIVE PACKAGING AS SMART PACKAGING FOR NUTRACEUTICAL GUMMIES 116 6.4.5 IOT-ENABLED SMART MANUFACTURING AND ITS FUTURE APPLICATION IN NUTRACEUTICAL GUMMY PRODUCTION 117 6.5 IMPACT OF GENERATIVE AI ON NUTRACEUTICAL GUMMIES MARKET 117 6.5.1 INTRODUCTION 117 6.5.2 USE OF GENERATIVE AI ON NUTRACEUTICAL GUMMIES MARKET 118 6.5.3 TOP USE CASES AND MARKET POTENTIAL 118 6.5.4 BEST PRACTICES IN NUTRACEUTICAL INDUSTRY 119 6.5.5 CASE STUDIES OF AI IMPLEMENTATION IN NUTRACEUTICAL GUMMIES MARKET 119 6.5.6 INTERCONNECTED ADJACENT ECOSYSTEM AND IMPACT ON MARKET PLAYERS 120 6.5.7 CLIENTS’ READINESS TO ADOPT GENERATIVE AI NUTRACEUTICAL GUMMIES 120 7 REGULATORY LANDSCAPE AND SUSTAINABILITY INITIATIVES 121 7.1 REGIONAL REGULATIONS AND COMPLIANCE 121 7.1.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 121 7.1.2 INDUSTRY STANDARDS 123 7.1.3 LABELING REQUIREMENTS AND CLAIMS 124 7.1.4 ANTICIPATED REGULATORY CHANGES IN NEXT 5?10 YEARS 125 7.1.4.1 Mandatory validation of bioavailability & functional claims 125 7.1.4.2 Global harmonization of dietary supplement & nutraceutical classifications 125 7.1.4.3 Strengthened safety, contaminant, & additive control regulations 125 7.1.4.4 Digital labeling, traceability & QR-based compliance tracking 125 7.2 SUSTAINABILITY INITIATIVES 126 7.2.1 SUSTAINABLE SOURCING 126 7.2.2 CARBON FOOTPRINT REDUCTION INITIATIVES 126 7.2.3 CIRCULAR ECONOMY APPROACHES 127 7.3 IMPACT OF REGULATORY POLICIES ON SUSTAINABILITY INITIATIVES 127 7.4 CERTIFICATIONS, LABELING, ECO-STANDARDS 128 8 CUSTOMER LANDSCAPE AND BUYER BEHAVIOR 129 8.1 DECISION-MAKING PROCESS 129 8.2 KEY STAKEHOLDERS INVOLVED IN BUYING PROCESS AND THEIR EVALUATION CRITERIA 130 8.2.1 KEY STAKEHOLDERS IN BUYING PROCESS 130 8.2.2 BUYING CRITERIA 131 8.3 ADOPTION BARRIERS AND INTERNAL CHALLENGES 132 8.4 UNMET NEEDS OF VARIOUS APPLICATION INDUSTRIES ACROSS SUPPLY CHAIN 133 8.5 MARKET PROFITABILITY 134 8.6 REVENUE POTENTIAL 134 8.6.1 COST DYNAMICS 135 8.6.2 MARGIN OPPORTUNITIES, BY TYPE 136 9 NUTRACEUTICAL GUMMIES MARKET, BY TYPE 137 9.1 INTRODUCTION 138 9.2 B2C MARKET 139 9.2.1 ADVANCING CONSUMER HEALTH THROUGH FUNCTIONAL GUMMIES 139 9.3 B2B MARKET 139 9.3.1 POWERING BRANDS WITH SCALABLE, SCIENCE-DRIVEN GUMMY SOLUTIONS 139 10 NUTRACEUTICAL GUMMIES MARKET (B2B), BY CUSTOMER TYPE 140 10.1 INTRODUCTION 141 10.2 BRAND OWNERS & MARKETING COMPANIES 142 10.2.1 DEMAND FOR DIFFERENTIATED, CLEAN-LABEL, AND TREND-RESPONSIVE GUMMY FORMULATIONS TO BENEFIT CONTRACT MANUFACTURERS AND PRIVATE-LABEL PARTNERS 142 10.3 RETAILERS & DISTRIBUTORS 145 10.3.1 RAPID EXPANSION OF PRIVATE-LABEL SUPPLEMENTS AND OMNICHANNEL RETAIL STRATEGIES TO INCREASE RETAILER DEMAND FOR COST-EFFICIENT, HIGH-QUALITY GUMMY MANUFACTURING PARTNERSHIPS 145 10.4 HEALTHCARE & WELLNESS 147 10.4.1 GROWING INTEGRATION OF NUTRITION INTO PREVENTIVE CARE, PEDIATRICS, AND WELLNESS PROGRAMS TO DRIVE DEMAND FOR CLINICALLY CREDIBLE, COMPLIANCE-FRIENDLY GUMMY SUPPLEMENTS 147 10.5 PHARMACEUTICAL COMPANIES 149 10.5.1 PHARMACEUTICAL PLAYERS LEVERAGE NUTRACEUTICAL GUMMIES TO EXTEND CONSUMER HEALTH PORTFOLIOS BEYOND PRESCRIPTIONS WHILE MAINTAINING CLINICAL CREDIBILITY AND QUALITY DIFFERENTIATION 149 10.6 FOOD & BEVERAGE COMPANIES 151 10.6.1 CONVERGENCE OF INDULGENCE AND FUNCTIONALITY PROMPTING CONFECTIONERY AND FOOD COMPANIES TO EXPLORE FUNCTIONAL GUMMIES 151 11 NUTRACEUTICAL GUMMIES MARKET (B2B), BY PRODUCTION CAPACITY 154 11.1 INTRODUCTION 155 11.2 SMALL-SCALE CONTRACT MANUFACTURERS (<10 M UNITS/YEAR) 156 11.2.1 GROWING DEMAND FOR LOW-VOLUME, CUSTOMIZED GUMMY FORMULATIONS TO SUPPORT EMERGING NUTRACEUTICAL BRANDS 156 11.3 MID-SCALE MANUFACTURERS (10?50 M UNITS/YEAR) 157 11.3.1 INCREASING NEED FOR SCALABLE PRODUCTION WITH FORMULATION FLEXIBILITY TO SUPPORT BRAND EXPANSION AND REGIONAL MARKET PENETRATION 157 11.4 LARGE-SCALE INDUSTRIAL MANUFACTURERS (50+ M UNITS/YEAR) 159 11.4.1 RISING REQUIREMENT FOR HIGH-VOLUME, STANDARDIZED GUMMY PRODUCTION TO ENSURE SUPPLY CONSISTENCY FOR GLOBAL NUTRACEUTICAL BRANDS 159 12 NUTRACEUTICAL GUMMIES MARKET (B2B), BY INGREDIENT SOURCE 161 12.1 INTRODUCTION 162 12.2 ANIMAL-BASED SOURCES 163 12.2.1 COLLAGEN EFFICACY KEEPS ANIMAL-BASED INGREDIENTS DOMINANT 163 12.3 PLANT-BASED SOURCES 165 12.3.1 VEGAN AND CLEAN-LABEL DEMAND FUELS PLANT-BASED ADOPTION 165 12.4 MICROBIAL/FERMENTATION-DERIVED SOURCES 167 12.4.1 ADVANCEMENTS IN STABILIZED FERMENTATION TECHNOLOGIES TO EXPANDING ADOPTION OF MICROBIAL-DERIVED ACTIVES IN GUMMY FORMULATIONS 167 12.5 SYNTHETIC/CHEMICALLY-DERIVED SOURCES 169 12.5.1 CONSISTENCY AND SCALE TO SUSTAIN SYNTHETIC INGREDIENT USAGE 169 13 NUTRACEUTICAL GUMMIES MARKET (B2B), BY GUMMY BASE/EXCIPIENTS 172 13.1 INTRODUCTION 173 13.2 GELATIN-BASED GUMMIES 174 13.2.1 HIGH ACTIVE LOADING AND TEXTURE RELIABILITY TO CONTINUE DRIVING GELATIN USAGE 174 13.3 PECTIN-BASED GUMMIES 175 13.3.1 VEGAN POSITIONING AND CLEAN-LABEL DEMAND TO ACCELERATE PECTIN ADOPTION 175 13.4 STARCH-BASED GUMMIES 176 13.4.1 COST PRESSURE AND LARGE-SCALE PRODUCTION NEEDS TO SUSTAIN STARCH-BASED SYSTEMS 176 13.5 AGAR, CARRAGEENAN, AND OTHER HYDROCOLLOIDS 177 14 NUTRACEUTICAL GUMMIES MARKET (B2C), BY PRODUCT TYPE 179 14.1 INTRODUCTION 180 14.2 VITAMINS 181 14.2.1 RISING INSTANCES OF VITAMIN DEFICIENCIES TO DRIVE SEGMENT 181 14.2.2 MULTIVITAMINS 183 14.2.3 VITAMIN C 184 14.2.4 VITAMIN D 185 14.2.5 VITAMIN B COMPLEX 186 14.2.6 VITAMIN E AND A 187 14.3 MINERALS 189 14.3.1 MEETING ESSENTIAL MINERAL NEEDS THROUGH CONVENIENT, PALATABLE SUPPLEMENTATION FOR EVERYDAY HEALTH SUPPORT 189 14.3.2 CALCIUM 191 14.3.3 IRON 191 14.3.4 ZINC 192 14.3.5 MAGNESIUM 193 14.4 OMEGA-3 FATTY ACIDS 194 14.5 PROBIOTICS & PREBIOTICS 196 14.5.1 INCREASED INTEREST IN SKIN CARE AMONG CONSUMERS TO BOOST MARKET 196 14.6 COLLAGEN & BEAUTY-FROM-WITHIN 197 14.6.1 INCREASED INTEREST IN SKIN CARE AMONG CONSUMERS TO BOOST MARKET 197 14.7 HERBAL & BOTANICAL 199 14.7.1 RISING CONSUMER PREFERENCE FOR PLANT-BASED NATURAL INGREDIENTS TO DRIVE SEGMENT 199 14.7.2 ASHWAGANDHA 201 14.7.3 TURMERIC/CURCUMIN 202 14.7.4 ELDERBERRY 203 14.7.5 MELATONIN 204 14.7.6 OTHER HERBAL AND BOTANICAL GUMMIES 205 14.8 DIETARY FIBER 205 14.9 CBD & CANNABIS-DERIVED 206 14.10 SPECIALTY FORMULATIONS 208 14.10.1 HEALTH-PROMOTING PROPERTIES TO AUGMENT SEGMENT GROWTH 208 15 NUTRACEUTICAL GUMMIES MARKET(B2C), BY FUNCTIONALITY 209 15.1 INTRODUCTION 210 15.2 IMMUNITY SUPPORT 211 15.2.1 RISING FOCUS ON IMPROVING IMMUNITY TO DRIVE MARKET 211 15.3 GENERAL HEALTH & WELLNESS 212 15.3.1 GROWING NUTRITIONAL DEFICIENCIES AND PREVENTIVE HEALTHCARE TRENDS TO DRIVE MARKET 212 15.4 BONE & JOINT HEALTH 213 15.4.1 RISING CASES OF OSTEOPOROSIS TO PROPEL MARKET GROWTH 213 15.5 WEIGHT MANAGEMENT 215 15.5.1 RISING PREVALENCE OF OBESITY AND METABOLIC DISORDERS TO DRIVE MARKET 215 15.6 BEAUTY & SKIN HEALTH 216 15.6.1 INCREASING FOCUS ON APPEARANCE AND OVERALL SKIN WELLNESS TO DRIVE MARKET 216 16 NUTRACEUTICAL GUMMIES MARKET (B2C), BY DEMOGRAPHICS 219 16.1 INTRODUCTION 220 16.2 GENERATION ALPHA (0?12 YEARS) 221 16.2.1 EARLY-LIFE SUPPLEMENTATION AND DIGITAL-FIRST PARENTING TO FUEL DEMAND FOR PEDIATRIC NUTRACEUTICAL GUMMIES 221 16.3 GENERATION Z (13?28 YEARS) 222 16.3.1 FOCUS ON HEALTH AND DAILY SELF-CARE TO FUEL GUMMY SUPPLEMENT DEMAND 222 16.4 MILLENNIALS (GEN Y) (29?44 YEARS) 224 16.4.1 LIFESTYLE-DRIVEN WELLNESS CHOICES TO POWER NUTRACEUTICAL ADOPTION 224 16.5 GENERATION X (45?60 YEARS) 225 16.5.1 WILLINGNESS TO INVEST IN HEALTH-ENHANCING NUTRITION SOLUTIONS TO DRIVE MARKET 225 16.6 BABY BOOMERS AND OLDER (61+ YEARS) 226 16.6.1 HEALTHY AGING PRIORITIES TO DRIVE NUTRACEUTICAL USE 226 17 NUTRACEUTICAL GUMMIES MARKET (B2C), BY DISTRIBUTION CHANNEL 228 17.1 INTRODUCTION 229 17.2 OFFLINE CHANNELS 230 17.2.1 HYPERMARKETS & SUPERMARKETS 232 17.2.1.1 Preferred purchasing destination and availability of variants to drive growth 232 17.2.2 PHARMACIES & DRUGSTORES 233 17.2.2.1 Wide presence and around-the-clock services to drive growth 233 17.2.3 SPECIALTY HEALTH STORES 234 17.2.3.1 Enabling premium and targeted gummy supplement sales 234 17.2.4 CONVENIENCE STORES 235 17.2.4.1 Preference toward specialized healthcare products to fuel growth 235 17.2.5 MASS MERCHANDISERS AND MULTI-LEVEL MARKETING (MLM) 236 17.2.5.1 High-volume retail and network-based selling drive offline expansion 236 17.3 ONLINE CHANNELS 237 18 NUTRACEUTICAL GUMMIES MARKET, BY REGION 239 18.1 INTRODUCTION 240 18.2 NORTH AMERICA 244 18.2.1 US 264 18.2.1.1 Presence of key players and various health trends to boost market 264 18.2.2 CANADA 267 18.2.2.1 Convenience, taste, and health benefits to drive demand for nutraceutical gummies 267 18.2.3 MEXICO 269 18.2.3.1 Rising health-conscious and vegan population to drive market 269 18.3 EUROPE 271 18.3.1 GERMANY 291 18.3.1.1 Growing interest in health & wellness to drive market 291 18.3.2 UK 293 18.3.2.1 Rising prevalence of diseases to drive market 293 18.3.3 FRANCE 296 18.3.3.1 High healthcare costs and increased demand for dietary supplements to drive market 296 18.3.4 SPAIN 298 18.3.4.1 Adoption of healthy lifestyles to drive market 298 18.3.5 ITALY 301 18.3.5.1 Strong e-commerce system and rising geriatric population to drive market 301 18.3.6 REST OF EUROPE 303 18.4 ASIA PACIFIC 305 18.4.1 CHINA 325 18.4.1.1 Large population and increasing prevalence of diseases to drive market 325 18.4.2 JAPAN 328 18.4.2.1 Rising awareness and shifting preferences toward dietary supplements to drive market 328 18.4.3 INDIA 330 18.4.3.1 Rising disposable incomes and growing focus on wellness to drive market 330 18.4.4 AUSTRALIA & NEW ZEALAND 333 18.4.4.1 High demand for dietary supplements, particularly in new formats, to drive market 333 18.4.5 REST OF ASIA PACIFIC 335 18.5 SOUTH AMERICA 338 18.5.1 BRAZIL 357 18.5.1.1 Increasing consumer preference for convenient and palatable formats in nutrient intake to drive market 357 18.5.2 ARGENTINA 360 18.5.2.1 Growing focus on prevention of micronutrient deficiencies and cardiometabolic risks to drive market 360 18.5.3 REST OF SOUTH AMERICA 362 18.6 REST OF THE WORLD 364 18.6.1 MIDDLE EAST 383 18.6.1.1 Rising disposable incomes and healthcare costs to drive market 383 18.6.2 AFRICA 386 18.6.2.1 Increase in vitamin deficiency and consumer awareness about health supplements to fuel market 386 19 COMPETITIVE LANDSCAPE 389 19.1 OVERVIEW 389 19.2 B2C PLAYER COMPETITIVE STRATEGIES/RIGHT TO WIN, 2020?2025 389 19.3 REVENUE ANALYSIS (B2C MARKET), 2022?2024 391 19.4 MARKET SHARE ANALYSIS (B2C MARKET), 2024 392 19.5 MARKET SHARE ANALYSIS (B2B MARKET), 2024 394 19.6 BRAND/PRODUCT COMPARISON 396 19.7 COMPANY EVALUATION MATRIX: B2C COMPANIES, 2024 397 19.7.1 STARS 398 19.7.2 EMERGING LEADERS 398 19.7.3 PERVASIVE PLAYERS 398 19.7.4 PARTICIPANTS 398 19.7.5 COMPANY FOOTPRINT: B2C NUTRACEUTICAL GUMMIES COMPANIES, 2024 400 19.7.5.1 Company footprint 400 19.7.5.2 Regional footprint 401 19.7.5.3 Product type footprint 402 19.7.5.4 Functionality footprint 403 19.8 COMPANY EVALUATION MATRIX: B2B COMPANIES, 2024 404 19.8.1 STARS 404 19.8.2 EMERGING LEADERS 404 19.8.3 PERVASIVE PLAYERS 404 19.8.4 PARTICIPANTS 405 19.8.5 COMPETITIVE BENCHMARKING 406 19.8.5.1 Detailed list of B2B key players 406 19.8.6 COMPETITIVE BENCHMARKING: B2B COMPANIES, 2024 407 19.8.6.1 Competitive benchmarking of key B2B companies 407 19.9 COMPANY VALUATION AND FINANCIAL METRICS 408 19.10 COMPETITIVE SCENARIO 409 19.10.1 PRODUCT LAUNCHES 409 19.10.2 DEALS 413 19.10.3 EXPANSIONS 416 19.10.4 OTHER DEVELOPMENTS 418 20 COMPANY PROFILES 419 20.1 B2C PLAYERS (BRAND MANUFACTURERS) 419 20.1.1 CHURCH & DWIGHT CO., INC. 419 20.1.1.1 Business overview 419 20.1.1.2 Products/Solutions/Services offered 420 20.1.1.3 Recent developments 421 20.1.1.3.1 Product launches 421 20.1.1.4 MnM view 422 20.1.1.4.1 Key strengths 422 20.1.1.4.2 Strategic choices 422 20.1.1.4.3 Weaknesses and competitive threats 422 20.1.2 H&H GROUP 423 20.1.2.1 Business overview 423 20.1.2.2 Products/Solutions/Services offered 424 20.1.2.3 Recent developments 425 20.1.2.3.1 Deals 425 20.1.2.3.2 Expansions 426 20.1.2.3.3 Other developments 426 20.1.2.4 MnM view 427 20.1.2.4.1 Key strengths 427 20.1.2.4.2 Strategic choices 427 20.1.2.4.3 Weaknesses and competitive threats 427 20.1.3 AMWAY 428 20.1.3.1 Business overview 428 20.1.3.2 Products/Solutions/Services offered 429 20.1.3.3 Recent developments 430 20.1.3.3.1 Product launches 430 20.1.3.3.2 Deals 431 20.1.3.4 MnM view 431 20.1.3.4.1 Key strengths 431 20.1.3.4.2 Strategic choices 431 20.1.3.4.3 Weaknesses and competitive threats 431 ? 20.1.4 BAYER AG 432 20.1.4.1 Business overview 432 20.1.4.2 Products/Solutions/Services offered 433 20.1.4.3 Recent developments 435 20.1.4.3.1 Product launches 435 20.1.4.4 MnM view 435 20.1.4.4.1 Key strengths 435 20.1.4.4.2 Strategic choices 435 20.1.4.4.3 Weaknesses and competitive threats 435 20.1.5 HALEON GROUP OF COMPANIES 436 20.1.5.1 Business overview 436 20.1.5.2 Products/Solutions/Services offered 437 20.1.5.3 Recent developments 439 20.1.5.3.1 Product launches 439 20.1.5.3.2 Deals 440 20.1.5.3.3 Expansions 440 20.1.5.4 MnM view 440 20.1.5.4.1 Key strengths 440 20.1.5.4.2 Strategic choices 441 20.1.5.4.3 Weaknesses and competitive threats 441 20.1.6 NESTLE 442 20.1.6.1 Business overview 442 20.1.6.2 Products/Solutions/Services offered 443 20.1.6.3 Recent developments 445 20.1.6.3.1 Product launches 445 20.1.6.3.2 Deals 445 20.1.6.4 MnM view 446 20.1.6.4.1 Key strengths 446 20.1.6.4.2 Strategic choices 446 20.1.6.4.3 Weaknesses and competitive threats 446 20.1.7 UNILEVER 447 20.1.7.1 Business overview 447 20.1.7.2 Products/Solutions/Services offered 448 20.1.7.3 Recent developments 449 20.1.7.3.1 Product launches 449 20.1.7.3.2 Deals 449 20.1.7.3.3 Expansions 450 20.1.7.4 MnM view 450 20.1.7.4.1 Key strengths 450 20.1.7.4.2 Strategic choices 450 20.1.7.4.3 Weaknesses and competitive threats 450 ? 20.1.8 OTSUKA HOLDINGS CO., LTD. 451 20.1.8.1 Business overview 451 20.1.8.2 Products/Solutions/Services offered 452 20.1.8.3 Recent developments 453 20.1.8.3.1 Product launches 453 20.1.8.3.2 Expansions 454 20.1.8.4 MnM view 454 20.1.8.4.1 Key strengths 454 20.1.8.4.2 Strategic choices 454 20.1.8.4.3 Weaknesses and competitive threats 455 20.1.9 PHARMACARE LABORATORIES 456 20.1.9.1 Business overview 456 20.1.9.2 Products/Solutions/Services offered 456 20.1.9.3 Recent developments 457 20.1.9.3.1 Expansions 457 20.1.9.4 MnM view 458 20.1.10 SWANSON 459 20.1.10.1 Business overview 459 20.1.10.2 Products/Solutions/Services offered 459 20.1.10.3 Recent developments 460 20.1.10.3.1 Product launches 460 20.1.10.4 MnM view 460 20.1.11 IM HEALTHCARE 461 20.1.11.1 Business overview 461 20.1.11.2 Products/Solutions/Services offered 461 20.1.11.3 Recent developments 462 20.1.11.4 MnM view 462 20.1.12 SMP NUTRA 463 20.1.12.1 Business overview 463 20.1.12.2 Products/Solutions/Services offered 463 20.1.12.3 Recent developments 464 20.1.12.4 MnM view 464 20.1.13 NATURE’S TRUTH 465 20.1.13.1 Business overview 465 20.1.13.2 Products/Solutions/Services offered 465 20.1.13.3 Recent developments 466 20.1.13.3.1 Other developments 466 20.1.13.4 MnM view 466 20.1.14 HERBALAND NATURALS INC. 467 20.1.14.1 Business overview 467 20.1.14.2 Products/Solutions/Services offered 467 ? 20.1.14.3 Recent developments 468 20.1.14.4 MnM view 468 20.1.15 BOSCOGEN, INC. 469 20.1.15.1 Business overview 469 20.1.15.2 Products/Solutions/Services offered 469 20.1.15.3 Recent developments 469 20.1.15.4 MnM view 469 20.2 B2B PLAYERS (CONTRACT MANUFACTURERS) 470 20.2.1 SOFGEN PHARMA 470 20.2.1.1 Business overview 470 20.2.1.2 Products/Services/Solutions offered 471 20.2.1.3 Recent developments 472 20.2.1.3.1 Expansions 472 20.2.1.4 MnM view 473 20.2.1.4.1 Key strengths 473 20.2.1.4.2 Strategic choices 473 20.2.1.4.3 Weaknesses & competitive threats 473 20.2.2 CATALENT, INC. 474 20.2.2.1 Business overview 474 20.2.2.2 Products/Services/Solutions offered 474 20.2.2.3 Recent developments 475 20.2.2.3.1 Deals 475 20.2.2.4 MnM view 475 20.2.2.4.1 Key strengths 475 20.2.2.4.2 Strategic choices 475 20.2.2.4.3 Weaknesses & competitive threats 475 20.2.3 ACTIV'INSIDE 476 20.2.3.1 Business overview 476 20.2.3.2 Products/Services/Solutions offered 476 20.2.3.3 Recent developments 477 20.2.3.4 MnM view 477 20.2.3.4.1 Key strengths 477 20.2.3.4.2 Strategic choices 477 20.2.3.4.3 Weaknesses & competitive threats 477 20.2.4 SIRIO PHARMA CO., LTD. 478 20.2.4.1 Business overview 478 20.2.4.2 Products/Services/Solutions offered 479 20.2.4.3 Recent developments 480 20.2.4.3.1 Product launches 480 20.2.4.4 MnM view 480 ? 20.2.5 WIN NUTRA 481 20.2.5.1 Business overview 481 20.2.5.2 Products/Services/Solutions offered 481 20.2.5.3 Recent developments 482 20.2.5.4 MnM view 482 20.2.6 MAKERS NUTRITION, LLC 483 20.2.6.1 Business overview 483 20.2.6.2 Products/Services/Solutions offered 484 20.2.6.3 Recent developments 485 20.2.6.4 MnM view 485 20.2.7 ION LABS 486 20.2.7.1 Business overview 486 20.2.7.2 Products/Services/Solutions offered 487 20.2.7.3 Recent developments 487 20.2.7.3.1 Expansions 487 20.2.7.3.2 Deals 488 20.2.7.4 MnM view 488 20.2.8 VITAJOY GROUP 489 20.2.8.1 Business overview 489 20.2.8.2 Products/Services/Solutions offered 490 20.2.8.3 Recent developments 490 20.2.8.4 MnM view 490 20.2.9 BLISS LIFESCIENCES LLP 491 20.2.9.1 Business overview 491 20.2.9.2 Products/Services/Solutions offered 491 20.2.9.3 Recent developments 492 20.2.9.4 MnM view 492 20.2.10 GLOBAL WIDGET 493 20.2.10.1 Business overview 493 20.2.10.2 Products/Services/Solutions offered 494 20.2.10.3 Recent developments 495 20.2.10.3.1 Product launches 495 20.2.10.3.2 Deals 496 20.2.10.3.3 Expansions 496 20.2.10.4 MnM view 496 20.2.11 GUMMY WORLDS 497 20.2.12 TOPGUM 498 20.2.13 MERICAL 499 20.2.14 FERMENTIS LIFE SCIENCES 500 20.2.15 EAGLE LABS, INC. 501 ? 21 RESEARCH METHODOLOGY 502 21.1 RESEARCH DATA 502 21.1.1 SECONDARY DATA 503 21.1.1.1 Key data from secondary sources 503 21.1.2 PRIMARY DATA 504 21.1.2.1 Key industry insights 504 21.1.2.2 Breakdown of primary interviews 505 21.1.2.3 Primary sources 505 21.2 MARKET SIZE ESTIMATION 506 21.2.1 NUTRACEUTICAL GUMMIES MARKET SIZE ESTIMATION: SUPPLY SIDE 507 21.2.2 NUTRACEUTICAL GUMMIES MARKET SIZE ESTIMATION: DEMAND SIDE 507 21.2.3 NUTRACEUTICAL GUMMIES MARKET SIZE ESTIMATION: BOTTOM-UP APPROACH 508 21.2.4 NUTRACEUTICAL GUMMIES MARKET SIZE ESTIMATION: TOP-DOWN APPROACH 510 21.3 DATA TRIANGULATION 511 21.4 RESEARCH ASSUMPTIONS 512 21.5 RESEARCH LIMITATIONS 512 22 ADJACENT & RELATED MARKETS 513 22.1 INTRODUCTION 513 22.2 LIMITATIONS 513 22.3 NUTRACEUTICAL INGREDIENTS MARKET 514 22.3.1 MARKET DEFINITION 514 22.3.2 MARKET OVERVIEW 514 22.4 DIETARY SUPPLEMENTS MARKET 515 22.4.1 MARKET DEFINITION 515 22.4.2 MARKET OVERVIEW 515 23 APPENDIX 517 23.1 DISCUSSION GUIDE 517 23.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 525 23.3 CUSTOMIZATION OPTIONS 527 23.4 RELATED REPORTS 527 23.5 AUTHOR DETAILS 528

ページTOPに戻る

List of Tables/Graphs

TABLE 1 USD EXCHANGE RATES, 2020?2024 53
TABLE 2 IMPACT OF PORTER’S FIVE FORCES NUTRACEUTICAL GUMMIES MARKET 81
TABLE 3 NUTRACEUTICAL GUMMIES MARKET: SUPPLY CHAIN (ECOSYSTEM) 91
TABLE 4 AVERAGE SELLING PRICE (ASP) OF NUTRACEUTICAL GUMMIES, BY KEY PLAYER, 2023 (USD/UNIT) 92
TABLE 5 AVERAGE SELLING PRICE (ASP) TREND OF NUTRACEUTICAL GUMMIES, BY REGION, 2021?2024 (USD/TON) 95
TABLE 6 IMPORT AND EXPORT SCENARIO FOR HS CODE: 210690, BY COUNTRY, 2024 97
TABLE 7 IMPORT AND EXPORT SCENARIO FOR HS CODE: 210690, BY COUNTRY, 2023 97
TABLE 8 NUTRACEUTICAL GUMMIES MARKET: LIST OF KEY CONFERENCES AND EVENTS, 2026?2027 98
TABLE 9 US-ADJUSTED RECIPROCAL TARIFF RATES 103
TABLE 10 PATENTS PERTAINING TO NUTRACEUTICAL GUMMIES, 2019?2025 113
TABLE 11 TOP USE CASES AND MARKET POTENTIAL 118
TABLE 12 BEST PRACTICES: COMPANIES IMPLEMENTING USE CASES 119
TABLE 13 NUTRACEUTICAL GUMMIES MARKET: CASE STUDIES RELATED TO GEN AI IMPLEMENTATION 119
TABLE 14 INTERCONNECTED ADJACENT ECOSYSTEM AND IMPACT ON MARKET PLAYERS 120
TABLE 15 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 121
TABLE 16 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 122
TABLE 17 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 122
TABLE 18 SOUTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 123
TABLE 19 INTERNATIONAL: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 123
TABLE 20 GLOBAL INDUSTRY STANDARDS IN NUTRACEUTICAL GUMMIES MARKET 124
TABLE 21 LABELING REQUIREMENTS AND CLAIMS IN NUTRACEUTICAL GUMMIES MARKET 124
TABLE 22 CERTIFICATIONS, LABELING, AND ECO-STANDARDS IN NUTRACEUTICAL GUMMIES MARKET 128
TABLE 23 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP PRODUCT TYPES 131
TABLE 24 KEY BUYING CRITERIA FOR TOP PRODUCT TYPES 131
TABLE 25 UNMET NEEDS IN NUTRACEUTICAL GUMMIES MARKET, BY KEY INDUSTRIES ACROSS SUPPLY CHAIN 133
TABLE 26 COST DYNAMICS IN NUTRACEUTICAL GUMMIES MARKET 135
TABLE 27 MARGIN OPPORTUNITIES IN NUTRACEUTICAL GUMMIES MARKET, BY TYPE 136
TABLE 28 NUTRACEUTICAL GUMMIES MARKET, BY TYPE, 2021?2024 (USD MILLION) 138
TABLE 29 NUTRACEUTICAL GUMMIES MARKET, BY TYPE, 2025?2030 (USD MILLION) 138
TABLE 30 NUTRACEUTICAL GUMMIES MARKET, BY TYPE, 2021?2024 (TONS) 138
TABLE 31 NUTRACEUTICAL GUMMIES MARKET, BY TYPE, 2025?2030 (TONS) 138
TABLE 32 NUTRACEUTICAL GUMMIES MARKET, BY CUSTOMER TYPE,
2021?2024 (USD MILLION) 141
TABLE 33 NUTRACEUTICAL GUMMIES MARKET, BY CUSTOMER TYPE,
2025?2030 (USD MILLION) 142
TABLE 34 BRAND OWNERS & MARKETING COMPANIES: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2021?2024 (USD MILLION) 144
TABLE 35 BRAND OWNERS & MARKETING COMPANIES: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2025?2030 (USD MILLION) 145
TABLE 36 RETAILERS & DISTRIBUTORS: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2021?2024 (USD MILLION) 146
TABLE 37 RETAILERS & DISTRIBUTORS: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2025?2030 (USD MILLION) 147
TABLE 38 HEALTHCARE & WELLNESS: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2021?2024 (USD MILLION) 149
TABLE 39 HEALTHCARE & WELLNESS: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2025?2030 (USD MILLION) 149
TABLE 40 PHARMACEUTICAL COMPANIES: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2021?2024 (USD MILLION) 151
TABLE 41 PHARMACEUTICAL COMPANIES: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2025?2030 (USD MILLION) 151
TABLE 42 FOOD & BEVERAGE COMPANIES: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2021?2024 (USD MILLION) 153
TABLE 43 FOOD & BEVERAGE COMPANIES: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2025?2030 (USD MILLION) 153
TABLE 44 NUTRACEUTICAL GUMMIES MARKET, BY PRODUCTION CAPACITY,
2021?2024 (USD MILLION) 155
TABLE 45 NUTRACEUTICAL GUMMIES MARKET, BY PRODUCTION CAPACITY,
2025?2030 (USD MILLION) 156
TABLE 46 SMALL-SCALE CONTRACT MANUFACTURERS: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2021?2024 (USD MILLION) 157
TABLE 47 SMALL-SCALE CONTRACT MANUFACTURERS: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2025?2030 (USD MILLION) 157
TABLE 48 MID-SCALE MANUFACTURERS: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2021?2024 (USD MILLION) 158
TABLE 49 MID-SCALE MANUFACTURERS: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2025?2030 (USD MILLION) 158
TABLE 50 LARGE-SCALE INDUSTRIAL MANUFACTURERS: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2021?2024 (USD MILLION) 159
TABLE 51 LARGE-SCALE INDUSTRIAL MANUFACTURERS: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2025?2030 (USD MILLION) 160
TABLE 52 NUTRACEUTICAL GUMMIES MARKET, BY INGREDIENT SOURCE,
2021?2024 (USD MILLION) 163
TABLE 53 NUTRACEUTICAL GUMMIES MARKET, BY INGREDIENT SOURCE,
2025?2030 (USD MILLION) 163
TABLE 54 ANIMAL-BASED SOURCES: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2021?2024 (USD MILLION) 164
TABLE 55 ANIMAL-BASED SOURCES: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2025?2030 (USD MILLION) 165
TABLE 56 PLANT-BASED SOURCES: NUTRACEUTICAL GUMMIES MARKET, BY REGION,
2021?2024 (USD MILLION) 166
TABLE 57 PLANT-BASED SOURCES: NUTRACEUTICAL GUMMIES MARKET, BY REGION,
2025?2030 (USD MILLION) 167
TABLE 58 MICROBIAL/FERMENTATION-DERIVED SOURCES: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2021?2024 (USD MILLION) 168
TABLE 59 MICROBIAL/FERMENTATION-DERIVED SOURCES: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2025?2030 (USD MILLION) 169
TABLE 60 SYNTHETIC/CHEMICALLY-DERIVED SOURCES: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2021?2024 (USD MILLION) 170
TABLE 61 SYNTHETIC/CHEMICALLY-DERIVED SOURCES: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2025?2030 (USD MILLION) 171
TABLE 62 NUTRACEUTICAL GUMMIES MARKET, BY GUMMY BASE/EXCIPIENTS,
2021?2024 (USD MILLION) 174
TABLE 63 NUTRACEUTICAL GUMMIES MARKET, BY GUMMY BASE/EXCIPIENTS,
2025?2030 (USD MILLION) 174
TABLE 64 GELATIN-BASED GUMMIES: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2021?2024 (USD MILLION) 175
TABLE 65 GELATIN-BASED GUMMIES: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2025?2030 (USD MILLION) 175
TABLE 66 PECTIN-BASED GUMMIES: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2021?2024 (USD MILLION) 176
TABLE 67 PECTIN-BASED GUMMIES: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2025?2030 (USD MILLION) 176
TABLE 68 STARCH-BASED GUMMIES: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2021?2024 (USD MILLION) 177
TABLE 69 STARCH-BASED GUMMIES: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2025?2030 (USD MILLION) 177
TABLE 70 AGAR, CARRAGEENAN, AND OTHER HYDROCOLLOIDS: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2021?2024 (USD MILLION) 178
TABLE 71 AGAR, CARRAGEENAN, AND OTHER HYDROCOLLOIDS: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2025?2030 (USD MILLION) 178
TABLE 72 NUTRACEUTICAL GUMMIES MARKET, BY PRODUCT TYPE,
2021?2024 (USD MILLION) 181
TABLE 73 NUTRACEUTICAL GUMMIES MARKET, BY PRODUCT TYPE,
2025?2030 (USD MILLION) 181
TABLE 74 VITAMINS: NUTRACEUTICAL GUMMIES MARKET, BY TYPE,
2021?2024 (USD MILLION) 182
TABLE 75 VITAMINS: NUTRACEUTICAL GUMMIES MARKET, BY TYPE,
2025?2030 (USD MILLION) 182
TABLE 76 VITAMINS: NUTRACEUTICAL GUMMIES MARKET, BY REGION,
2021?2024 (USD MILLION) 182
TABLE 77 VITAMIN GUMMIES: NUTRACEUTICAL GUMMIES MARKET, BY REGION,
2025?2030 (USD MILLION) 183
TABLE 78 MULTIVITAMINS: NUTRACEUTICAL GUMMIES MARKET, BY REGION,
2021?2024 (USD MILLION) 183
TABLE 79 MULTIVITAMINS: NUTRACEUTICAL GUMMIES MARKET, BY REGION,
2025?2030 (USD MILLION) 184
TABLE 80 VITAMIN C: NUTRACEUTICAL GUMMIES MARKET, BY REGION,
2021?2024 (USD MILLION) 184
TABLE 81 VITAMIN C: NUTRACEUTICAL GUMMIES MARKET, BY REGION,
2025?2030 (USD MILLION) 185
TABLE 82 VITAMIN D: NUTRACEUTICAL GUMMIES MARKET, BY REGION,
2021?2024 (USD MILLION) 185
TABLE 83 VITAMIN D: NUTRACEUTICAL GUMMIES MARKET, BY REGION,
2025?2030 (USD MILLION) 186
TABLE 84 VITAMIN B COMPLEX: NUTRACEUTICAL GUMMIES MARKET, BY REGION,
2021?2024 (USD MILLION) 187
TABLE 85 VITAMIN B COMPLEX: NUTRACEUTICAL GUMMIES MARKET, BY REGION,
2025?2030 (USD MILLION) 187
TABLE 86 VITAMIN E & A: NUTRACEUTICAL GUMMIES MARKET, BY REGION,
2021?2024 (USD MILLION) 188
TABLE 87 VITAMIN E & A: NUTRACEUTICAL GUMMIES MARKET, BY REGION,
2025?2030 (USD MILLION) 188
TABLE 88 MINERALS: NUTRACEUTICAL GUMMIES MARKET, BY TYPE,
2021?2024 (USD MILLION) 189
TABLE 89 MINERALS: NUTRACEUTICAL GUMMIES MARKET, BY TYPE,
2025?2030 (USD MILLION) 190
TABLE 90 MINERALS: NUTRACEUTICAL GUMMIES MARKET, BY REGION,
2021?2024 (USD MILLION) 190
TABLE 91 MINERALS: NUTRACEUTICAL GUMMIES MARKET, BY REGION,
2025?2030 (USD MILLION) 190
TABLE 92 CALCIUM: NUTRACEUTICAL GUMMIES MARKET, BY REGION,
2021?2024 (USD MILLION) 191
TABLE 93 CALCIUM: NUTRACEUTICAL GUMMIES MARKET, BY REGION,
2025?2030 (USD MILLION) 191
TABLE 94 IRON: NUTRACEUTICAL GUMMIES MARKET, BY REGION,
2021?2024 (USD MILLION) 192
TABLE 95 IRON: NUTRACEUTICAL GUMMIES MARKET, BY REGION,
2025?2030 (USD MILLION) 192
TABLE 96 ZINC: NUTRACEUTICAL GUMMIES MARKET, BY REGION,
2021?2024 (USD MILLION) 192
TABLE 97 ZINC: NUTRACEUTICAL GUMMIES MARKET, BY REGION,
2025?2030 (USD MILLION) 193
TABLE 98 MAGNESIUM: NUTRACEUTICAL GUMMIES MARKET, BY REGION,
2021?2024 (USD MILLION) 193
TABLE 99 MAGNESIUM: NUTRACEUTICAL GUMMIES MARKET, BY REGION,
2025?2030 (USD MILLION) 194
TABLE 100 OMEGA-3 FATTY ACIDS: NUTRACEUTICAL GUMMIES MARKET, BY REGION,
2021?2024 (USD MILLION) 195
TABLE 101 OMEGA-3 FATTY ACIDS: NUTRACEUTICAL GUMMIES MARKET, BY REGION,
2025?2030 (USD MILLION) 196
TABLE 102 PROBIOTICS & PREBIOTICS: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2021?2024 (USD MILLION) 197
TABLE 103 PROBIOTICS & PREBIOTICS: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2025?2030 (USD MILLION) 197
TABLE 104 COLLAGEN & BEAUTY-FROM-WITHIN: NUTRACEUTICAL GUMMIES MARKET,
BY REGION, 2021?2024 (USD MILLION) 198
TABLE 105 COLLAGEN & BEAUTY-FROM-WITHIN: NUTRACEUTICAL GUMMIES MARKET,
BY REGION, 2025?2030 (USD MILLION) 199
TABLE 106 HERBAL & BOTANICAL: NUTRACEUTICAL GUMMIES MARKET, BY TYPE, 2021?2024 (USD MILLION) 199
TABLE 107 HERBAL & BOTANICAL: NUTRACEUTICAL GUMMIES MARKET, BY TYPE, 2025?2030 (USD MILLION) 200
TABLE 108 HERBAL & BOTANICAL: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2021?2024 (USD MILLION) 200
TABLE 109 HERBAL & BOTANICAL: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2025?2030 (USD MILLION) 200
TABLE 110 ASHWAGANDHA: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2021?2024 (USD MILLION) 201
TABLE 111 ASHWAGANDHA: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2025?2030 (USD MILLION) 201
TABLE 112 TURMERIC/CURCUMIN: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2021?2024 (USD MILLION) 202
TABLE 113 TURMERIC/CURCUMIN: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2025?2030 (USD MILLION) 202
TABLE 114 ELDERBERRY: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2021?2024 (USD MILLION) 203
TABLE 115 ELDERBERRY: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2025?2030 (USD MILLION) 203
TABLE 116 MELATONIN: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2021?2024 (USD MILLION) 204
TABLE 117 MELATONIN: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2025?2030 (USD MILLION) 204
TABLE 118 OTHER HERBAL AND BOTANICAL GUMMIES: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2021?2024 (USD MILLION) 205
TABLE 119 OTHER HERBAL AND BOTANICAL GUMMIES: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2025?2030 (USD MILLION) 205
TABLE 120 DIETARY FIBER: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2021?2024 (USD MILLION) 206
TABLE 121 DIETARY FIBER: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2025?2030 (USD MILLION) 206
TABLE 122 CBD & CANNABIS-DERIVED: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2021?2024 (USD MILLION) 207
TABLE 123 CBD & CANNABIS-DERIVED: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2025?2030 (USD MILLION) 207
TABLE 124 SPECIALTY FORMULATIONS: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2021?2024 (USD MILLION) 208
TABLE 125 SPECIALTY FORMULATIONS: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2025?2030 (USD MILLION) 208
TABLE 126 NUTRACEUTICAL GUMMIES MARKET, BY FUNCTIONALITY, 2021?2024
(USD MILLION) 210
TABLE 127 NUTRACEUTICAL GUMMIES MARKET, BY FUNCTIONALITY, 2025?2030
(USD MILLION) 211
TABLE 128 IMMUNITY SUPPORT: NUTRACEUTICAL GUMMIES MARKET, BY REGION,
2021?2024 (USD MILLION) 211
TABLE 129 IMMUNITY SUPPORT GUMMIES: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2025?2030 (USD MILLION) 212
TABLE 130 GENERAL HEALTH & WELLNESS: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2021?2024 (USD MILLION) 213
TABLE 131 GENERAL HEALTH & WELLNESS: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2025?2030 (USD MILLION) 213
TABLE 132 BONE & JOINT HEALTH: NUTRACEUTICAL GUMMIES MARKET, BY REGION,
2021?2024 (USD MILLION) 214
TABLE 133 BONE & JOINT HEALTH: NUTRACEUTICAL GUMMIES MARKET, BY REGION,
2025?2030 (USD MILLION) 214
TABLE 134 WEIGHT MANAGEMENT: NUTRACEUTICAL GUMMIES MARKET, BY REGION,
2021?2024 (USD MILLION) 215
TABLE 135 WEIGHT MANAGEMENT: NUTRACEUTICAL GUMMIES MARKET, BY REGION,
2025?2030 (USD MILLION) 216
TABLE 136 BEAUTY & SKIN HEALTH: NUTRACEUTICAL GUMMIES MARKET, BY REGION,
2021?2024 (USD MILLION) 216
TABLE 137 BEAUTY & SKIN HEALTH: NUTRACEUTICAL GUMMIES MARKET, BY REGION,
2025?2030 (USD MILLION) 217
TABLE 138 OTHER FUNCTIONALITIES: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2021?2024 (USD MILLION) 217
TABLE 139 OTHER FUNCTIONALITIES: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2025?2030 (USD MILLION) 218
TABLE 140 NUTRACEUTICAL GUMMIES MARKET, BY DEMOGRAPHICS,
2021?2024 (USD MILLION) 221
TABLE 141 NUTRACEUTICAL GUMMIES MARKET, BY DEMOGRAPHICS,
2025?2030 (USD MILLION) 221
TABLE 142 GENERATION ALPHA (0?12 YEARS): NUTRACEUTICAL GUMMIES MARKET,
BY REGION, 2021?2024 (USD MILLION) 222
TABLE 143 GENERATION ALPHA (0?12 YEARS): NUTRACEUTICAL GUMMIES MARKET,
BY REGION, 2025?2030 (USD MILLION) 222
TABLE 144 GENERATION Z (13?28 YEARS): NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2021?2024 (USD MILLION) 223
TABLE 145 GENERATION Z (13?28 YEARS): NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2025?2030 (USD MILLION) 223
TABLE 146 MILLENNIALS (29?44 YEARS): NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2021?2024 (USD MILLION) 224
TABLE 147 MILLENNIALS (29?44 YEARS): NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2025?2030 (USD MILLION) 225
TABLE 148 GENERATION X (45?60 YEARS): NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2021?2024 (USD MILLION) 225
TABLE 149 GENERATION X (45?60 YEARS): NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2025?2030 (USD MILLION) 226
TABLE 150 BABY BOOMERS AND OLDER (61+ YEARS): NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2021?2024 (USD MILLION) 227
TABLE 151 BABY BOOMERS AND OLDER (61+ YEARS): NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2025?2030 (USD MILLION) 227
TABLE 152 NUTRACEUTICAL GUMMIES MARKET, BY DISTRIBUTION CHANNEL,
2021?2024 (USD MILLION) 229
TABLE 153 NUTRACEUTICAL GUMMIES MARKET, BY DISTRIBUTION CHANNEL,
2025?2030 (USD MILLION) 230
TABLE 154 OFFLINE CHANNELS: NUTRACEUTICAL GUMMIES MARKET, BY REGION,
2021?2024 (USD MILLION) 230
TABLE 155 OFFLINE CHANNELS: NUTRACEUTICAL GUMMIES MARKET, BY REGION,
2025?2030 (USD MILLION) 231
TABLE 156 OFFLINE CHANNELS: NUTRACEUTICAL GUMMIES MARKET, BY TYPE,
2021?2024 (USD MILLION) 231
TABLE 157 OFFLINE CHANNELS: NUTRACEUTICAL GUMMIES MARKET, BY TYPE,
2025?2030 (USD MILLION) 231
TABLE 158 HYPERMARKETS & SUPERMARKETS: NUTRACEUTICAL GUMMIES MARKET,
BY REGION, 2021?2024 (USD MILLION) 232
TABLE 159 HYPERMARKETS & SUPERMARKETS: NUTRACEUTICAL GUMMIES MARKET,
BY REGION, 2025?2030 (USD MILLION) 232
TABLE 160 PHARMACIES & DRUG STORES: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2021?2024 (USD MILLION) 233
TABLE 161 PHARMACIES & DRUG STORES: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2025?2030 (USD MILLION) 233
TABLE 162 SPECIALTY HEALTH STORES: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2021?2024 (USD MILLION) 234
TABLE 163 SPECIALTY HEALTH STORES: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2025?2030 (USD MILLION) 234
TABLE 164 CONVENIENCE STORES: NUTRACEUTICAL GUMMIES MARKET, BY REGION,
2021?2024 (USD MILLION) 235
TABLE 165 CONVENIENCE STORES: NUTRACEUTICAL GUMMIES MARKET, BY REGION,
2025?2030 (USD MILLION) 235
TABLE 166 MASS MERCHANDISERS AND MULTI-LEVEL MARKETING (MLM): NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2021?2024 (USD MILLION) 236
TABLE 167 MASS MERCHANDISERS AND MULTI-LEVEL MARKETING (MLM): NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2025?2030 (USD MILLION) 236
TABLE 168 ONLINE CHANNELS: NUTRACEUTICAL GUMMIES MARKET, BY REGION,
2021?2024 (USD MILLION) 237
TABLE 169 ONLINE CHANNELS: NUTRACEUTICAL GUMMIES MARKET, BY REGION,
2025?2030 (USD MILLION) 238
TABLE 170 B2B NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2021?2024 (USD MILLION) 241
TABLE 171 B2B NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2025?2030 (USD MILLION) 242
TABLE 172 B2B NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2021?2024 (TONS) 242
TABLE 173 B2B NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2025?2030 (TONS) 242
TABLE 174 B2C NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2021?2024 (USD MILLION) 243
TABLE 175 B2C NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2025?2030 (USD MILLION) 243
TABLE 176 B2C NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2021?2024 (TONS) 243
TABLE 177 B2C NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2025?2030 (TONS) 244
TABLE 178 NORTH AMERICA: B2B NUTRACEUTICAL GUMMIES MARKET, BY COUNTRY,
2021?2024 (USD MILLION) 245
TABLE 179 NORTH AMERICA: B2B NUTRACEUTICAL GUMMIES MARKET, BY COUNTRY,
2025?2030 (USD MILLION) 246
TABLE 180 NORTH AMERICA: B2B NUTRACEUTICAL GUMMIES MARKET, BY COUNTRY,
2021?2024 (TONS) 246
TABLE 181 NORTH AMERICA: B2B NUTRACEUTICAL GUMMIES MARKET, BY COUNTRY,
2025?2030 (TONS) 246
TABLE 182 NORTH AMERICA: B2C NUTRACEUTICAL GUMMIES MARKET, BY COUNTRY,
2021?2024 (USD MILLION) 246
TABLE 183 NORTH AMERICA: B2C NUTRACEUTICAL GUMMIES MARKET, BY COUNTRY,
2025?2030 (USD MILLION) 247
TABLE 184 NORTH AMERICA: B2C NUTRACEUTICAL GUMMIES MARKET, BY COUNTRY,
2021?2024 (TONS) 247
TABLE 185 NORTH AMERICA: B2C NUTRACEUTICAL GUMMIES MARKET, BY COUNTRY,
2025?2030 (TONS) 247
TABLE 186 NORTH AMERICA: B2B NUTRACEUTICAL GUMMIES MARKET, BY PRODUCTION CAPACITY, 2021?2024 (USD MILLION) 248
TABLE 187 NORTH AMERICA: B2B NUTRACEUTICAL GUMMIES MARKET, BY PRODUCTION CAPACITY, 2025?2030 (USD MILLION) 248
TABLE 188 NORTH AMERICA: B2B NUTRACEUTICAL GUMMIES MARKET, BY PRODUCTION CAPACITY, 2021?2024 (TONS) 248
TABLE 189 NORTH AMERICA: B2B NUTRACEUTICAL GUMMIES MARKET, BY PRODUCTION CAPACITY, 2025?2030 (TONS) 249
TABLE 190 NORTH AMERICA: B2B NUTRACEUTICAL GUMMIES MARKET, BY CUSTOMER TYPE, 2021?2024 (USD MILLION) 249
TABLE 191 NORTH AMERICA: B2B NUTRACEUTICAL GUMMIES MARKET, BY CUSTOMER TYPE, 2025?2030 (USD MILLION) 249
TABLE 192 NORTH AMERICA: B2B NUTRACEUTICAL GUMMIES MARKET, BY CUSTOMER TYPE, 2021?2024 (TONS) 250
TABLE 193 NORTH AMERICA: B2B NUTRACEUTICAL GUMMIES MARKET, BY CUSTOMER TYPE, 2025?2030 (TONS) 250
TABLE 194 NORTH AMERICA: B2B NUTRACEUTICAL GUMMIES MARKET, BY INGREDIENT SOURCE, 2021?2024 (USD MILLION) 250
TABLE 195 NORTH AMERICA: B2B NUTRACEUTICAL GUMMIES MARKET, BY INGREDIENT SOURCE, 2025?2030 (USD MILLION) 251
TABLE 196 NORTH AMERICA: B2B NUTRACEUTICAL GUMMIES MARKET, BY INGREDIENT SOURCE, 2021?2024 (TONS) 251
TABLE 197 NORTH AMERICA: B2B NUTRACEUTICAL GUMMIES MARKET, BY INGREDIENT SOURCE, 2025?2030 (TONS) 251
TABLE 198 NORTH AMERICA: B2B NUTRACEUTICAL GUMMIES MARKET, BY GUMMY BASE/EXCIPIENTS, 2021?2024 (USD MILLION) 252
TABLE 199 NORTH AMERICA: B2B NUTRACEUTICAL GUMMIES MARKET, BY GUMMY BASE/EXCIPIENTS, 2025?2030 (USD MILLION) 252
TABLE 200 NORTH AMERICA: B2B NUTRACEUTICAL GUMMIES MARKET, BY GUMMY BASE/EXCIPIENTS, 2021?2024 (TONS) 252
TABLE 201 NORTH AMERICA: B2B NUTRACEUTICAL GUMMIES MARKET, BY GUMMY BASE/EXCIPIENTS, 2025?2030 (TONS) 253
TABLE 202 NORTH AMERICA: B2C NUTRACEUTICAL GUMMIES MARKET, BY PRODUCT TYPE, 2021?2024 (USD MILLION) 253
TABLE 203 NORTH AMERICA: B2C NUTRACEUTICAL GUMMIES MARKET, BY PRODUCT TYPE, 2025?2030 (USD MILLION) 254
TABLE 204 NORTH AMERICA: B2C NUTRACEUTICAL GUMMIES MARKET, BY PRODUCT TYPE, 2021?2024 (TONS) 254
TABLE 205 NORTH AMERICA: B2C NUTRACEUTICAL GUMMIES MARKET, BY PRODUCT TYPE, 2025?2030 (TONS) 255
TABLE 206 NORTH AMERICA: B2C NUTRACEUTICAL GUMMIES MARKET, BY VITAMIN,
2021?2024 (USD MILLION) 255
TABLE 207 NORTH AMERICA: B2C NUTRACEUTICAL GUMMIES MARKET, BY VITAMIN,
2025?2030 (USD MILLION) 255
TABLE 208 NORTH AMERICA: B2C NUTRACEUTICAL GUMMIES MARKET, BY VITAMIN,
2021?2024 (TONS) 256
TABLE 209 NORTH AMERICA: B2C NUTRACEUTICAL GUMMIES MARKET, BY VITAMIN,
2025?2030 (TONS) 256
TABLE 210 NORTH AMERICA: B2C NUTRACEUTICAL GUMMIES MARKET, BY HERBAL & BOTANICAL, 2021?2024 (USD MILLION) 256
TABLE 211 NORTH AMERICA: B2C NUTRACEUTICAL GUMMIES MARKET, BY HERBAL & BOTANICAL, 2025?2030 (USD MILLION) 257
TABLE 212 NORTH AMERICA: B2C NUTRACEUTICAL GUMMIES MARKET, BY HERBAL & BOTANICAL, 2021?2024 (TONS) 257
TABLE 213 NORTH AMERICA: B2C NUTRACEUTICAL GUMMIES MARKET, BY HERBAL & BOTANICAL, 2025?2030 (TONS) 257
TABLE 214 NORTH AMERICA: B2C NUTRACEUTICAL GUMMIES MARKET, BY MINERAL,
2021?2024 (USD MILLION) 258
TABLE 215 NORTH AMERICA: B2C NUTRACEUTICAL GUMMIES MARKET, BY MINERAL,
2025?2030 (USD MILLION) 258
TABLE 216 NORTH AMERICA: B2C NUTRACEUTICAL GUMMIES MARKET, BY MINERAL,
2021?2024 (TONS) 258
TABLE 217 NORTH AMERICA: B2C NUTRACEUTICAL GUMMIES MARKET, BY MINERAL,
2025?2030 (TONS) 259
TABLE 218 NORTH AMERICA: B2C NUTRACEUTICAL GUMMIES MARKET, BY DISTRIBUTION CHANNEL, 2021?2024 (USD MILLION) 259
TABLE 219 NORTH AMERICA: B2C NUTRACEUTICAL GUMMIES MARKET, BY DISTRIBUTION CHANNEL, 2025?2030 (USD MILLION) 259
TABLE 220 NORTH AMERICA: B2C NUTRACEUTICAL GUMMIES MARKET, BY DISTRIBUTION CHANNEL, 2021?2024 (TONS) 259
TABLE 221 NORTH AMERICA: B2C NUTRACEUTICAL GUMMIES MARKET, BY DISTRIBUTION CHANNEL, 2025?2030 (TONS) 260
TABLE 222 NORTH AMERICA: B2C NUTRACEUTICAL GUMMIES MARKET, BY OFFLINE DISTRIBUTION CHANNEL, 2021?2024 (USD MILLION) 260
TABLE 223 NORTH AMERICA: B2C NUTRACEUTICAL GUMMIES MARKET, BY OFFLINE DISTRIBUTION CHANNEL, 2025?2030 (USD MILLION) 260
TABLE 224 NORTH AMERICA: B2C NUTRACEUTICAL GUMMIES MARKET, BY OFFLINE DISTRIBUTION CHANNEL, 2021?2024 (TONS) 261
TABLE 225 NORTH AMERICA: B2C NUTRACEUTICAL GUMMIES MARKET, BY OFFLINE DISTRIBUTION CHANNEL, 2025?2030 (TONS) 261
TABLE 226 NORTH AMERICA: B2C NUTRACEUTICAL GUMMIES MARKET, BY DEMOGRAPHICS, 2021?2024 (USD MILLION) 261
TABLE 227 NORTH AMERICA: B2C NUTRACEUTICAL GUMMIES MARKET, BY DEMOGRAPHICS, 2025?2030 (USD MILLION) 262
TABLE 228 NORTH AMERICA: B2C NUTRACEUTICAL GUMMIES MARKET, BY DEMOGRAPHICS, 2021?2024 (TONS) 262
TABLE 229 NORTH AMERICA: B2C NUTRACEUTICAL GUMMIES MARKET, BY DEMOGRAPHICS, 2025?2030 (TONS) 262
TABLE 230 NORTH AMERICA: B2C NUTRACEUTICAL GUMMIES MARKET, BY FUNCTIONALITY, 2021?2024 (USD MILLION) 263
TABLE 231 NORTH AMERICA: B2C NUTRACEUTICAL GUMMIES MARKET, BY FUNCTIONALITY, 2025?2030 (USD MILLION) 263
TABLE 232 NORTH AMERICA: B2C NUTRACEUTICAL GUMMIES MARKET, BY FUNCTIONALITY, 2021?2024 (TONS) 263
TABLE 233 NORTH AMERICA: B2C NUTRACEUTICAL GUMMIES MARKET, BY FUNCTIONALITY, 2025?2030 (TONS) 264
TABLE 234 US: B2B NUTRACEUTICAL GUMMIES MARKET, BY CUSTOMER TYPE,
2021?2024 (USD MILLION) 265
TABLE 235 US: B2B NUTRACEUTICAL GUMMIES MARKET, BY CUSTOMER TYPE,
2025?2030 (USD MILLION) 265
TABLE 236 US: B2C NUTRACEUTICAL GUMMIES MARKET, BY PRODUCT TYPE,
2021?2024 (USD MILLION) 266
TABLE 237 US: B2C NUTRACEUTICAL GUMMIES MARKET, BY PRODUCT TYPE,
2025?2030 (USD MILLION) 266
TABLE 238 CANADA: B2B NUTRACEUTICAL GUMMIES MARKET, BY CUSTOMER TYPE,
2021?2024 (USD MILLION) 268
TABLE 239 CANADA: B2B NUTRACEUTICAL GUMMIES MARKET, BY CUSTOMER TYPE,
2025?2030 (USD MILLION) 268
TABLE 240 CANADA: B2C NUTRACEUTICAL GUMMIES MARKET, BY PRODUCT TYPE,
2021?2024 (USD MILLION) 268
TABLE 241 CANADA: B2C NUTRACEUTICAL GUMMIES MARKET, BY PRODUCT TYPE,
2025?2030 (USD MILLION) 269
TABLE 242 MEXICO: B2B NUTRACEUTICAL GUMMIES MARKET, BY CUSTOMER TYPE,
2021?2024 (USD MILLION) 270
TABLE 243 MEXICO: B2B NUTRACEUTICAL GUMMIES MARKET, BY CUSTOMER TYPE,
2025?2030 (USD MILLION) 270
TABLE 244 MEXICO: B2C NUTRACEUTICAL GUMMIES MARKET, BY PRODUCT TYPE,
2021?2024 (USD MILLION) 270
TABLE 245 MEXICO: B2C NUTRACEUTICAL GUMMIES MARKET, BY PRODUCT TYPE,
2025?2030 (USD MILLION) 271
TABLE 246 EUROPE: B2B NUTRACEUTICAL GUMMIES MARKET, BY COUNTRY,
2021?2024 (USD MILLION) 272
TABLE 247 EUROPE: B2B NUTRACEUTICAL GUMMIES MARKET, BY COUNTRY,
2025?2030 (USD MILLION) 272
TABLE 248 EUROPE: B2B NUTRACEUTICAL GUMMIES MARKET, BY COUNTRY,
2021?2024 (TONS) 272
TABLE 249 EUROPE: B2B NUTRACEUTICAL GUMMIES MARKET, BY COUNTRY,
2025?2030 (TONS) 273
TABLE 250 EUROPE: B2C NUTRACEUTICAL GUMMIES MARKET, BY COUNTRY,
2021?2024 (USD MILLION) 273
TABLE 251 EUROPE: B2C NUTRACEUTICAL GUMMIES MARKET, BY COUNTRY,
2025?2030 (USD MILLION) 273
TABLE 252 EUROPE: B2C NUTRACEUTICAL GUMMIES MARKET, BY COUNTRY,
2021?2024 (TONS) 274
TABLE 253 EUROPE: B2C NUTRACEUTICAL GUMMIES MARKET, BY COUNTRY,
2025?2030 (TONS) 274
TABLE 254 EUROPE: B2B NUTRACEUTICAL GUMMIES MARKET, BY PRODUCTION CAPACITY, 2021?2024 (USD MILLION) 274
TABLE 255 EUROPE: B2B NUTRACEUTICAL GUMMIES MARKET, BY PRODUCTION CAPACITY, 2025?2030 (USD MILLION) 275
TABLE 256 EUROPE: B2B NUTRACEUTICAL GUMMIES MARKET, BY PRODUCTION CAPACITY, 2021?2024 (TONS) 275
TABLE 257 EUROPE: B2B NUTRACEUTICAL GUMMIES MARKET, BY PRODUCTION CAPACITY, 2025?2030 (TONS) 275
TABLE 258 EUROPE: B2B NUTRACEUTICAL GUMMIES MARKET, BY CUSTOMER TYPE,
2021?2024 (USD MILLION) 276
TABLE 259 EUROPE: B2B NUTRACEUTICAL GUMMIES MARKET, BY CUSTOMER TYPE,
2025?2030 (USD MILLION) 276
TABLE 260 EUROPE: B2B NUTRACEUTICAL GUMMIES MARKET, BY CUSTOMER TYPE,
2021?2024 (TONS) 276
TABLE 261 EUROPE: B2B NUTRACEUTICAL GUMMIES MARKET, BY CUSTOMER TYPE,
2025?2030 (TONS) 277
TABLE 262 EUROPE: B2B NUTRACEUTICAL GUMMIES MARKET, BY INGREDIENT SOURCE, 2021?2024 (USD MILLION) 277
TABLE 263 EUROPE: B2B NUTRACEUTICAL GUMMIES MARKET, BY INGREDIENT SOURCE, 2025?2030 (USD MILLION) 277
TABLE 264 EUROPE: B2B NUTRACEUTICAL GUMMIES MARKET, BY INGREDIENT SOURCE, 2021?2024 (TONS) 278
TABLE 265 EUROPE: B2B NUTRACEUTICAL GUMMIES MARKET, BY INGREDIENT SOURCE, 2025?2030 (TONS) 278
TABLE 266 EUROPE: B2B NUTRACEUTICAL GUMMIES MARKET, BY GUMMY BASE/EXCIPIENTS, 2021?2024 (USD MILLION) 278
TABLE 267 EUROPE: B2B NUTRACEUTICAL GUMMIES MARKET, BY GUMMY BASE/EXCIPIENTS, 2025?2030 (USD MILLION) 279
TABLE 268 EUROPE: B2B NUTRACEUTICAL GUMMIES MARKET, BY GUMMY BASE/EXCIPIENTS, 2021?2024 (TONS) 279
TABLE 269 EUROPE: B2B NUTRACEUTICAL GUMMIES MARKET, BY GUMMY BASE/EXCIPIENTS, 2025?2030 (TONS) 279
TABLE 270 EUROPE: B2C NUTRACEUTICAL GUMMIES MARKET, BY PRODUCT TYPE,
2021?2024 (USD MILLION) 280
TABLE 271 EUROPE: B2C NUTRACEUTICAL GUMMIES MARKET, BY PRODUCT TYPE,
2025?2030 (USD MILLION) 280
TABLE 272 EUROPE: B2C NUTRACEUTICAL GUMMIES MARKET, BY PRODUCT TYPE,
2021?2024 (TONS) 281
TABLE 273 EUROPE: B2C NUTRACEUTICAL GUMMIES MARKET, BY PRODUCT TYPE,
2025?2030 (TONS) 281
TABLE 274 EUROPE: B2C NUTRACEUTICAL GUMMIES MARKET, BY VITAMIN,
2021?2024 (USD MILLION) 282
TABLE 275 EUROPE: B2C NUTRACEUTICAL GUMMIES MARKET, BY VITAMIN,
2025?2030 (USD MILLION) 282
TABLE 276 EUROPE: B2C NUTRACEUTICAL GUMMIES MARKET, BY VITAMIN,
2021?2024 (TONS) 282
TABLE 277 EUROPE: B2C NUTRACEUTICAL GUMMIES MARKET, BY VITAMIN,
2025?2030 (TONS) 283
TABLE 278 EUROPE: B2C NUTRACEUTICAL GUMMIES MARKET, BY HERBAL & BOTANICAL, 2021?2024 (USD MILLION) 283
TABLE 279 EUROPE: B2C NUTRACEUTICAL GUMMIES MARKET, BY HERBAL & BOTANICAL, 2025?2030 (USD MILLION) 283
TABLE 280 EUROPE: B2C NUTRACEUTICAL GUMMIES MARKET, BY HERBAL & BOTANICAL, 2021?2024 (TONS) 284
TABLE 281 EUROPE: B2C NUTRACEUTICAL GUMMIES MARKET, BY HERBAL & BOTANICAL, 2025?2030 (TONS) 284
TABLE 282 EUROPE: B2C NUTRACEUTICAL GUMMIES MARKET, BY MINERAL,
2021?2024 (USD MILLION) 284
TABLE 283 EUROPE: B2C NUTRACEUTICAL GUMMIES MARKET, BY MINERAL,
2025?2030 (USD MILLION) 285
TABLE 284 EUROPE: B2C NUTRACEUTICAL GUMMIES MARKET, BY MINERAL,
2021?2024 (TONS) 285
TABLE 285 EUROPE: B2C NUTRACEUTICAL GUMMIES MARKET, BY MINERAL,
2025?2030 (TONS) 285
TABLE 286 EUROPE: B2C NUTRACEUTICAL GUMMIES MARKET, BY DISTRIBUTION CHANNEL, 2021?2024 (USD MILLION) 286
TABLE 287 EUROPE: B2C NUTRACEUTICAL GUMMIES MARKET, BY DISTRIBUTION CHANNEL, 2025?2030 (USD MILLION) 286
TABLE 288 EUROPE: B2C NUTRACEUTICAL GUMMIES MARKET, BY DISTRIBUTION CHANNEL, 2021?2024 (TONS) 286
TABLE 289 EUROPE: B2C NUTRACEUTICAL GUMMIES MARKET, BY DISTRIBUTION CHANNEL, 2025?2030 (TONS) 286
TABLE 290 EUROPE: B2C NUTRACEUTICAL GUMMIES MARKET, BY OFFLINE DISTRIBUTION CHANNEL, 2021?2024 (USD MILLION) 287
TABLE 291 EUROPE: B2C NUTRACEUTICAL GUMMIES MARKET, BY OFFLINE DISTRIBUTION CHANNEL, 2025?2030 (USD MILLION) 287
TABLE 292 EUROPE: B2C NUTRACEUTICAL GUMMIES MARKET, BY OFFLINE DISTRIBUTION CHANNEL, 2021?2024 (TONS) 287
TABLE 293 EUROPE: B2C NUTRACEUTICAL GUMMIES MARKET, BY OFFLINE DISTRIBUTION CHANNEL, 2025?2030 (TONS) 288
TABLE 294 EUROPE: B2C NUTRACEUTICAL GUMMIES MARKET, BY DEMOGRAPHICS,
2021?2024 (USD MILLION) 288
TABLE 295 EUROPE: B2C NUTRACEUTICAL GUMMIES MARKET, BY DEMOGRAPHICS,
2025?2030 (USD MILLION) 288
TABLE 296 EUROPE: B2C NUTRACEUTICAL GUMMIES MARKET, BY DEMOGRAPHICS,
2021?2024 (TONS) 289
TABLE 297 EUROPE: B2C NUTRACEUTICAL GUMMIES MARKET, BY DEMOGRAPHICS,
2025?2030 (TONS) 289
TABLE 298 EUROPE: B2C NUTRACEUTICAL GUMMIES MARKET, BY FUNCTIONALITY,
2021?2024 (USD MILLION) 289
TABLE 299 EUROPE: B2C NUTRACEUTICAL GUMMIES MARKET, BY FUNCTIONALITY,
2025?2030 (USD MILLION) 290
TABLE 300 EUROPE: B2C NUTRACEUTICAL GUMMIES MARKET, BY FUNCTIONALITY,
2021?2024 (TONS) 290
TABLE 301 EUROPE: B2C NUTRACEUTICAL GUMMIES MARKET, BY FUNCTIONALITY,
2025?2030 (TONS) 290
TABLE 302 GERMANY: B2B NUTRACEUTICAL GUMMIES MARKET, BY CUSTOMER TYPE,
2021?2024 (USD MILLION) 292
TABLE 303 GERMANY: B2B NUTRACEUTICAL GUMMIES MARKET, BY CUSTOMER TYPE,
2025?2030 (USD MILLION) 292
TABLE 304 GERMANY: B2C NUTRACEUTICAL GUMMIES MARKET, BY PRODUCT TYPE,
2021?2024 (USD MILLION) 292
TABLE 305 GERMANY: B2C NUTRACEUTICAL GUMMIES MARKET, BY PRODUCT TYPE,
2025?2030 (USD MILLION) 293
TABLE 306 UK: B2B NUTRACEUTICAL GUMMIES MARKET, BY CUSTOMER TYPE,
2021?2024 (USD MILLION) 294
TABLE 307 UK: B2B NUTRACEUTICAL GUMMIES MARKET, BY CUSTOMER TYPE,
2025?2030 (USD MILLION) 294
TABLE 308 UK: B2C NUTRACEUTICAL GUMMIES MARKET, BY PRODUCT TYPE,
2021?2024 (USD MILLION) 295
TABLE 309 UK: B2C NUTRACEUTICAL GUMMIES MARKET, BY PRODUCT TYPE,
2025?2030 (USD MILLION) 295
TABLE 310 FRANCE: B2B NUTRACEUTICAL GUMMIES MARKET, BY CUSTOMER TYPE,
2021?2024 (USD MILLION) 297
TABLE 311 FRANCE: B2B NUTRACEUTICAL GUMMIES MARKET, BY CUSTOMER TYPE,
2025?2030 (USD MILLION) 297
TABLE 312 FRANCE: B2C NUTRACEUTICAL GUMMIES MARKET, BY PRODUCT TYPE,
2021?2024 (USD MILLION) 297
TABLE 313 FRANCE: B2C NUTRACEUTICAL GUMMIES MARKET, BY PRODUCT TYPE,
2025?2030 (USD MILLION) 298
TABLE 314 SPAIN: B2B NUTRACEUTICAL GUMMIES MARKET, BY CUSTOMER TYPE,
2021?2024 (USD MILLION) 299
TABLE 315 SPAIN: B2B NUTRACEUTICAL GUMMIES MARKET, BY CUSTOMER TYPE,
2025?2030 (USD MILLION) 299
TABLE 316 SPAIN: B2C NUTRACEUTICAL GUMMIES MARKET, BY PRODUCT TYPE,
2021?2024 (USD MILLION) 300
TABLE 317 SPAIN: B2C NUTRACEUTICAL GUMMIES MARKET, BY PRODUCT TYPE,
2025?2030 (USD MILLION) 300TABLE 318 ITALY: B2B NUTRACEUTICAL GUMMIES MARKET, BY CUSTOMER TYPE,
2021?2024 (USD MILLION) 302
TABLE 319 ITALY: B2B NUTRACEUTICAL GUMMIES MARKET, BY CUSTOMER TYPE,
2025?2030 (USD MILLION) 302
TABLE 320 ITALY: B2C NUTRACEUTICAL GUMMIES MARKET, BY PRODUCT TYPE,
2021?2024 (USD MILLION) 302
TABLE 321 ITALY: B2C NUTRACEUTICAL GUMMIES MARKET, BY PRODUCT TYPE,
2025?2030 (USD MILLION) 303
TABLE 322 REST OF EUROPE: B2B NUTRACEUTICAL GUMMIES MARKET, BY CUSTOMER TYPE, 2021?2024 (USD MILLION) 304
TABLE 323 REST OF EUROPE: B2B NUTRACEUTICAL GUMMIES MARKET, BY CUSTOMER TYPE, 2025?2030 (USD MILLION) 304
TABLE 324 REST OF EUROPE: B2C NUTRACEUTICAL GUMMIES MARKET, BY PRODUCT TYPE, 2021?2024 (USD MILLION) 304
TABLE 325 REST OF EUROPE: B2C NUTRACEUTICAL GUMMIES MARKET, BY PRODUCT TYPE, 2025?2030 (USD MILLION) 305
TABLE 326 ASIA PACIFIC: B2B NUTRACEUTICAL GUMMIES MARKET, BY COUNTRY,
2021?2024 (USD MILLION) 306
TABLE 327 ASIA PACIFIC: B2B NUTRACEUTICAL GUMMIES MARKET, BY COUNTRY,
2025?2030 (USD MILLION) 307
TABLE 328 ASIA PACIFIC: B2B NUTRACEUTICAL GUMMIES MARKET, BY COUNTRY,
2021?2024 (TONS) 307
TABLE 329 ASIA PACIFIC: B2B NUTRACEUTICAL GUMMIES MARKET, BY COUNTRY,
2025?2030 (TONS) 307
TABLE 330 ASIA PACIFIC: B2C NUTRACEUTICAL GUMMIES MARKET, BY COUNTRY,
2021?2024 (USD MILLION) 308
TABLE 331 ASIA PACIFIC: B2C NUTRACEUTICAL GUMMIES MARKET, BY COUNTRY,
2025?2030 (USD MILLION) 308
TABLE 332 ASIA PACIFIC: B2C NUTRACEUTICAL GUMMIES MARKET, BY COUNTRY,
2021?2024 (TONS) 308
TABLE 333 ASIA PACIFIC: B2C NUTRACEUTICAL GUMMIES MARKET, BY COUNTRY,
2025?2030 (TONS) 309
TABLE 334 ASIA PACIFIC: B2B NUTRACEUTICAL GUMMIES MARKET, BY PRODUCTION CAPACITY, 2021?2024 (USD MILLION) 309
TABLE 335 ASIA PACIFIC: B2B NUTRACEUTICAL GUMMIES MARKET, BY PRODUCTION CAPACITY, 2025?2030 (USD MILLION) 309
TABLE 336 ASIA PACIFIC: B2B NUTRACEUTICAL GUMMIES MARKET, BY PRODUCTION CAPACITY, 2021?2024 (TONS) 310
TABLE 337 ASIA PACIFIC: B2B NUTRACEUTICAL GUMMIES MARKET, BY PRODUCTION CAPACITY, 2025?2030 (TONS) 310
TABLE 338 ASIA PACIFIC: B2B NUTRACEUTICAL GUMMIES MARKET, BY CUSTOMER TYPE, 2021?20